Journal of Interdisciplinary Genomics

Interdisciplinary Society of Genetic & Genomic Medicine (유전의학융합회)
권호 표지
DOI QR코드

DOI QR Code

Laboratory Misdiagnosis of von Willebrand Disease Caused by Preanalytical Issues: Sample Collection, Transportation, and Processing

  • Kim, In-Suk (Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine)
  • Received : 2020.02.14
  • Accepted : 2020.04.01
  • Published : 2020.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

von Willebrand disease (VWD) is a genetic bleeding disorders caused by a deficiency of von Willebrand factor (VWF). Diagnosis or exclusion of VWD is not an easy task for most clinicians. These difficulties in diagnosis or exclusion of VWD may be due to preanalytic, analytical and postanalytic laboratory issues. Analytical systems to diagnose VWD may produce misleading results because of limitations in their dynamic range of measurement and low sensitivity. However, preanalytical issues such as sample collection, processing, and transportation affect the diagnosis of VWD profoundly. We will review here the common preanlytical issues that may impact the laboratory diagnosis of VWD.

Keywords

References

  1. Favaloro EJ, Koutts J. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology. 1997;29(4):385-91. Epub 1998/01/10. doi: 10.1080/00313029700169365. PubMed PMID: 9423220.
  2. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4(10):2103-14. Epub 2006/08/08. doi: 10.1111/j.1538-7836.2006.02146.x. PubMed PMID: 16889557.
  3. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171-232. Epub 2008/03/05. doi: 10.1111/j.1365-2516.2007.01643.x. PubMed PMID: 18315614.
  4. Favaloro EJ, Pasalic L, Curnow J. Laboratory tests used to help diagnose von Willebrand disease: an update. Pathology. 2016;48(4):303-18. Epub 2016/05/02. doi: 10.1016/j.pathol.2016.03.001. PubMed PMID: 27131932.
  5. Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods Mol Biol. 2017;1646:29-42. Epub 2017/08/15. doi: 10.1007/978-1-4939-7196-1_2. PubMed PMID: 28804816.
  6. Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost. 2012;38(6):565-75. Epub 2012/06/07. doi: 10.1055/s-0032-1315961. PubMed PMID: 22669757.
  7. Clinical and Laboratory Standard Institute. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline, 5th ed. CLSI document H21-A5. 2008;2008.
  8. Lippi G, Salvagno GL, Brocco G, Gelati M, Danese E, Favaloro EJ. Impact of experimental hypercalcemia on routine haemostasis testing. PLoS One. 2017;12(3):e0175094. Epub 2017/04/01. doi: 10.1371/journal.pone.0175094. PubMed PMID: 28362859; PubMed Central PMCID: PMCPMC5376338.
  9. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol. 1995;104(3):264-71. Epub 1995/09/01. doi: 10.1093/ajcp/104.3.264. PubMed PMID: 7677113.
  10. Favaloro EJ, Oliver S. Evaluation of a new commercial von Willebrand factor multimer assay. Haemophilia. 2017;23(4):e373-e7. Epub 2017/05/13. doi: 10.1111/hae.13261. PubMed PMID: 28497866.
  11. Lippi G, Plebani M, Favaloro EJ. The changing face of hemostasis testing in modern laboratories: consolidation, automation, and beyond. Semin Thromb Hemost. 2015;41(3):294-9. Epub 2015/02/24. doi: 10.1055/s-0035-1544196. PubMed PMID: 25703516.
  12. Marshall AL, Dasari H, Warner ND, Grill DE, Nichols WL, Pruthi RK. Self-reported reproductive health experiences in women with von Willebrand disease: a qualitative interview-based study. J Obstet Gynaecol. 2019;39(2):288-90. Epub 2018/09/13. doi: 10.1080/01443615.2018.1472223. PubMed PMID: 30207499.
  13. Bohm M, Taschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Blood Coagul Fibrinolysis. 2006;17(1):39-45. Epub 2006/04/12. doi: 10.1097/01.mbc.0000198990.16598.85. PubMed PMID: 16607078.
  14. Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing. Am J Clin Pathol. 2004;122(5):686-92. Epub 2004/10/20. doi: 10.1309/E494-7DG4-8TVY-19C2. PubMed PMID: 15491964.
  15. Favaloro EJ, Wong RC. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology. 2014;46(6):481-95. Epub 2014/08/28. doi: 10.1097/PAT.0000000000000142. PubMed PMID: 25158812.
  16. Favaloro EJ, Mohammed A, Coombs R, Mehrabani PA. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory. Br J Biomed Sci. 1995;52(4):243-8. Epub 1995/12/01. PubMed PMID: 8555777.
  17. McCraw A, Hillarp A, Echenagucia M. Considerations in the laboratory assessment of haemostasis. Haemophilia. 2010;16 Suppl 5:74-8. Epub 2010/07/16. doi: 10.1111/j.1365-2516.2010.02302.x. PubMed PMID: 20590860.
  18. Favaloro EJ, Mehrabani PA. Laboratory assessment of von Willebrand factor: differential influence of prolonged ambient temperature specimen storage on assay results. Haemophilia. 1996;2(4):218-23. Epub 1996/10/01. doi: 10.1111/j.1365-2516.1996.tb00140.x. PubMed PMID: 27214360.
  19. Lima-Oliveira G, Adcock DM, Salvagno GL, Favaloro EJ, Lippi G. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? Clin Biochem. 2016;49(18):1399-401. Epub 2016/11/03. doi: 10.1016/j.clinbiochem.2016.10.009. PubMed PMID: 27769865.
  20. Favaloro EJ, Oliver S, Mohammed S, Ahuja M, Grzechnik E, Azimulla S, et al. Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma. Haemophilia. 2017;23(5):e436-e43. Epub 2017/07/28. doi: 10.1111/hae.13305. PubMed PMID: 28750474.
  21. Favaloro EJ, Lippi G. Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease. Haemophilia. 2018;24(2):198-210. Epub 2017/12/23. doi: 10.1111/hae.13396. PubMed PMID: 29271545.
  22. Lippi G, Baird GS, Banfi G, Bolenius K, Cadamuro J, Church S, et al. Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2017;55(4):489-500. Epub 2017/02/24. doi: 10.1515/cclm-2017-0107. PubMed PMID: 28231060.